» Articles » PMID: 1686899

Amyotrophic Lateral Sclerosis: Glutamate Dehydrogenase and Transmitter Amino Acids in the Spinal Cord

Overview
Date 1991 Nov 1
PMID 1686899
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Measurements were taken of the activity of glutamate dehydrogenase (GDH) and the levels of transmitter amino acids in anatomically dissected regions of cervical and lumbar spinal cord in eight patients dying with amyotrophic lateral sclerosis (ALS) and in 11 neurologically normal controls. GDH activity was considerably increased in lateral and ventral white matter and in the dorsal horn of the ALS cervical spinal cord, but normal in the ventral horn and the dorsal columns. Similar, although less pronounced, GDH changes were found in the lumbar enlargement. The mean concentrations of aspartate and glutamate were reduced in all regions of ALS spinal cord investigated. Taurine concentrations were significantly increased in several subdivisions of cervical spinal cord, but normal in lumbar regions. Glycine levels were significantly reduced in lumbar ventral and dorsal horns. There was no striking change in spinal cord GABA levels in our ALS patients. It is suggested that the reduced levels of glutamate and aspartate as well as the elevated GDH activity in the spinal cord of ALS patients may reflect an overactivity of the neurons releasing these potentially excitotoxic amino acids and thus may be causally related to the spinal neuro-degenerative changes characteristic of ALS.

Citing Articles

Neuroprotection by upregulation of the major histocompatibility complex class I (MHC I) in SOD1 mice.

Tomiyama A, Cartarozzi L, Coser L, Bortolanca Chiarotto G, Oliveira A Front Cell Neurosci. 2023; 17:1211486.

PMID: 37711512 PMC: 10498468. DOI: 10.3389/fncel.2023.1211486.


Inhibitory interneurons show early dysfunction in a SOD1 mouse model of amyotrophic lateral sclerosis.

Cavarsan C, Steele P, Genry L, Reedich E, McCane L, LaPre K J Physiol. 2022; 601(3):647-667.

PMID: 36515374 PMC: 9898203. DOI: 10.1113/JP284192.


Glial Glutamine Homeostasis in Health and Disease.

Andersen J, Schousboe A Neurochem Res. 2022; 48(4):1100-1128.

PMID: 36322369 DOI: 10.1007/s11064-022-03771-1.


Plasma taurine is an axonal excitability-translatable biomarker for amyotrophic lateral sclerosis.

Nakazato T, Kanai K, Kataura T, Nojiri S, Hattori N, Saiki S Sci Rep. 2022; 12(1):9155.

PMID: 35650294 PMC: 9160240. DOI: 10.1038/s41598-022-13397-6.


Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis.

Boussicault L, Laffaire J, Schmitt P, Rinaudo P, Callizot N, Nabirotchkin S J Neurosci Res. 2020; 98(12):2435-2450.

PMID: 32815196 PMC: 7693228. DOI: 10.1002/jnr.24714.


References
1.
Finocchiaro G, Taroni F, Di Donato S . Glutamate dehydrogenase in olivopontocerebellar atrophies: leukocytes, fibroblasts, and muscle mitochondria. Neurology. 1986; 36(4):550-3. DOI: 10.1212/wnl.36.4.550. View

2.
Perry T, Hansen S, Gandham S . Postmortem changes of amino compounds in human and rat brain. J Neurochem. 1981; 36(2):406-10. DOI: 10.1111/j.1471-4159.1981.tb01608.x. View

3.
Chee P, Dahl J, FAHIEN L . The purification and properties of rat brain glutamate dehydrogenase. J Neurochem. 1979; 33(1):53-60. DOI: 10.1111/j.1471-4159.1979.tb11705.x. View

4.
Yoshino Y, Koike H, Akai K . Free amino acids in motor cortex of amyotrophic lateral sclerosis. Experientia. 1979; 35(2):219-20. DOI: 10.1007/BF01920627. View

5.
Robinson N . Chemical changes in the spinal cord in Friedreich's ataxia and motor neurone disease. J Neurol Neurosurg Psychiatry. 1968; 31(4):330-3. PMC: 496370. DOI: 10.1136/jnnp.31.4.330. View